Highlights Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
125.5 ^USD	+0.81%		-3.05%	+15.15%

May. 31	Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	RE
May. 31	Sector Update: Health Care	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	May. 31	RE
Sector Update: Health Care	May. 31	MT
US Equities Markets Close Lower Thursday After Q1 Economic Growth Found to be Slower Than Projected	May. 30	MT
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar	May. 30	MT
Summit Therapeutics Shares Triple After Drug Candidate Data	May. 30	DJ
Summit Therapeutics cancer therapy succeeds in late-stage China study	May. 30	RE
Merck Signs MoU with KAIST to Advance Scientific Collaboration	May. 29	CI
Sector Update: Health Care Stocks Fall Late Afternoon	May. 29	MT
Sector Update: Health Care Stocks Retreat Wednesday Afternoon	May. 29	MT
Sector Update: Health Care	May. 29	MT
Top Midday Stories: Cleveland Fed Hires Goldman Veteran as Next CEO; BHP to Walk From Anglo Bid; ConocoPhillips Acquires Marathon; American Airlines Lowers Q2 Guidance	May. 29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	May. 29
Trending : Merck to Buy Biotech Company EyeBio for $1.3 Billion	May. 29	DJ
Merck acquires EyeBio for $1.3 billion	May. 29	CF
Merck to Acquire EyeBio for Up to $3 Billion	May. 29	MT
FDA Grants Priority Review to Merck & Co., Inc.'s Application for KEYTRUDA (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma	May. 29	CI
Merck to Acquire EyeBio for $1.3 Billion	May. 29	DJ
Merck to acquire eye drug company EyeBio for up to $3 bln	May. 29	RE
Merck Signs Deal to Buy Eyebiotech for Up to $3 Billion, Financial Times Reports	May. 29	MT
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports	May. 28	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Merck & Co., Inc.

Equities

MRK

US58933Y1055

Highlights

Filters